Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| DUB-IN-2 | C15H9N5O | 924296-19-5 | Details |
| Duocarmycin MA | C34H31ClN4O5 | 1613286-57-9 | Details |
| Duocarmycin MB | C27H26ClN3O4 | 1613286-58-0 | Details |
| Duloxetine metabolite Para-Naphthol Duloxetine；Para-Naphthol duloxetine | C18H19NOS | 949095-98-1 | Details |
| Duocarmycin GA | C26H25ClN4O3 | 1613286-59-1 | Details |
| Duloxetine D3 hydrochloride；LY248686 D3 hydrochloride;(S)-Duloxetine D3 hydrochloride | C18H20ClNOS | 1435727-97-1 | Details |
| Durlobactam sodium salt；ETX2514 | C8H12N3NaO6S | 1467157-21-6 | Details |
| Durvalumab；MEDI 4736 | 1428935-60-7 | Details |
| Dutogliptin tartrate；PHX-1149 | C14H26BN3O9 | 890402-81-0 | Details |
| Dutogliptin；PHX-1149 free base | C10H20BN3O3 | 852329-66-9 | Details |
| Duvelisib (R enantiomer)；INK1197 R enantiomer;Duvelisib R enantiomer;IPI-145 R enantiomer | C22H17ClN6O | 1261590-48-0 | Details |
| Duramycin；Moli1901;Lancovutide | C89H125N23O25S3 | 1391-36-2 | Details |
| DuP 105 | C13H16N2O4S | 96800-41-8 | Details |
| DUPA(OtBu)-OH | C23H40N2O9 | 1026987-94-9 | Details |
| Duocarmycin TM | C25H23ClN2O5 | 157922-77-5 | Details |
| Duoperone | C28H26F4N2OS | 62030-88-0 | Details |
| Duocarmycin DM free base；Duocarmycin | C26H26ClN3O3 | 1116745-06-2 | Details |
| 2-(Hydroxymethyl)pyridine；Piconol | C6H7NO | 586-98-1 | Details |
| DUB-IN-3 | C16H9N5O | 924296-17-3 | Details |
| Duocarmycin SA | C25H23N3O7 | 130288-24-3 | Details |
| DVD-445 | C25H28F2N2O4 | 2375846-41-4 | Details |
| DW14800 | C31H36N4O3 | 2243709-60-4 | Details |
| DYRKs-IN-1 | C30H30ClN7O4 | 1387090-01-8 | Details |
| DYRKs-IN-2 | C32H38ClN9O3 | 1386980-04-6 | Details |
| DZ2002 | C10H13N5O3 | 33231-14-0 | Details |
| (E)-10-Hydroxynortriptyline maleate；(E)-10-Hydroxy Nortriptyline maleate | C23H25NO5 | 74853-74-0 | Details |
| E-7386 | C39H48FN9O4 | 1799824-08-0 | Details |
| (E)-GABAB receptor antagonist 1 | C18H24O4 | 1611483-29-4 | Details |
| LHF-535 | C27H28N2O2 | 1450929-77-7 | Details |
| (E/Z)-BCI；NSC 150117 | C22H23NO | 15982-84-0 | Details |
| Ciclopirox olamine；Ciclopirox ethanolamine | C14H24N2O3 | 41621-49-2 | Details |
| E6130 | C28H37ClF3N3O3 | 1427058-33-0 | Details |
| E64FC26 | C19H23F3O2 | 2285446-62-8 | Details |
| EACC | C13H11N3O6S2 | 864941-31-1 | Details |
| EB-47 | C24H27N9O6 | 366454-36-6 | Details |
| EC0488 | C65H98N16O34S | 1059477-92-7 | Details |
| EC1454 | C65H98N16O34S | 1602487-15-9 | Details |
| EC359 | C36H38F2O2 | 2012591-09-0 | Details |
| EC5026；BPN-19186 | C18H23F4N3O3 | 1809885-32-2 | Details |
| Ecastolol | C26H33N3O6 | 77695-52-4 | Details |
| Ecopladib；PLA 725 | C39H33Cl3N2O5S | 381683-92-7 | Details |
| Doxylamine succinate；Decapryn | C21H28N2O5 | 562-10-7 | Details |
| Ecteinascidin 770；Et-770;Ecteinascidine 770 | C40H42N4O10S | 114899-80-8 | Details |
| Ecteinascidin-Analog-1 | C31H44N2O9 | 874758-58-4 | Details |
| Edaravone-d5；MCI-186 D5;Edaravone D5 | C10H10N2O | 1228765-67-0 | Details |
| EG00229 | C19H20F3N7O7S3 | 1210945-69-9 | Details |
| EG01377 | C26H30N6O6S2 | 2227996-00-9 | Details |
| Eg5 Inhibitor V, trans-24 | C26H21N3O3 | 869304-55-2 | Details |
| Nazartinib S-enantiomer；EGF816 (S-enantiomer) | C26H31ClN6O2 | 1508256-20-9 | Details |
| Nazartinib mesylate；EGF816 (mesylate) | C27H35ClN6O5S | 1508250-72-3 | Details |
| EGFR-IN-1 | C28H30N6O4 | 1625677-63-5 | Details |
| Biotin；D-Biotin;Vitamin H;Vitamin B7 | C10H16N2O3S | 58-85-5 | Details |
| EGFR-IN-5 | C31H38FN9O | 2225887-26-1 | Details |
| Emixustat；ACU-4429 | C16H25NO2 | 1141777-14-1 | Details |
| EMT inhibitor-2 | C24H26N2O8 | 2232228-60-1 | Details |
| Imazalil；Enilconazole;chloramizole | C14H14Cl2N2O | 35554-44-0 | Details |
| EML741 | C31H49N5O2 | 2328074-38-8 | Details |
| EMPA | C23H26N4O4S | 680590-49-2 | Details |
| EML4-ALK kinase inhibitor 1；EML4-?ALK kinase inhibitor 1 | C31H48N8O3 | 1373409-08-5 | Details |
| EMDT oxalate | C15H22N2O | 263744-72-5 | Details |
| EMD638683 S-Form | C18H18F2N2O4 | 1184940-46-2 | Details |
| Embramine | C18H22BrNO | 3565-72-8 | Details |
| EMD638683 R-Form | C18H18F2N2O4 | 1184940-47-3 | Details |
| Cefprozil monohydrate；Cefprozil;Cefprozil hydrate | C18H21N3O6S | 121123-17-9 | Details |
| ELN318463 racemate；ELN 318463 racemate | C19H20BrClN2O3S | 851599-82-1 | Details |
| Elubrixin；SB-656933 | C17H17Cl2FN4O4S | 688763-64-6 | Details |
| eIF4A3-IN-1 | C29H23BrClN5O2 | 2095486-67-0 | Details |
| EHNA hydrochloride | C14H24ClN5O | 58337-38-5 | Details |
| Eicosatetraynoic acid；ETYA | C20H24O2 | 1191-85-1 | Details |
| Clorgyline hydrochloride；Clorgiline hydrochloride | C13H16Cl3NO | 17780-75-5 | Details |
| eIF4A3-IN-2 | C25H19Br2ClN4O2 | 2095677-20-4 | Details |
| EIPA hydrochloride；L593754 hydrochloride;MH 12-43 hydrochloride | C11H19Cl2N7O | 1345839-28-2 | Details |
| (R)-Elagolix；NBI-56418 | C32H30F5N3O5 | 834153-87-6 | Details |
| Elenbecestat；E2609 | C19H18F3N5O2S | 1388651-30-6 | Details |
| Eliglustat hemitartrate；Genz-112638;Eliglustat tartrate | C50H78N4O14 | 928659-70-5 | Details |
| Elinogrel；PRT060128 | C20H15ClFN5O5S2 | 936500-94-6 | Details |
| ELN318463；ELN 318463 | C19H20BrClN2O3S | 851600-86-7 | Details |
| EGFR-IN-1 hydrochloride | C28H31ClN6O4 | 2227455-78-7 | Details |
| EGFR-IN-2 | C26H33N9O3S | 1643497-70-4 | Details |
| EGFR-IN-7；TQB3804 | C32H41BrN9O2P | 2267329-76-8 | Details |
| EGFR-IN-8 | C32H23ClF3N7O4 | 2407957-87-1 | Details |
| EGFR-IN-9 | C29H24N4O3 | 1226549-39-8 | Details |
| EGLU；(2S)-α-Ethylglutamic acid;(2S)-α-EGLU | C7H13NO4 | 170984-72-2 | Details |
| EHMT2-IN-1 | C18H23N7O | 2230849-55-3 | Details |
| EHMT2-IN-2 | C21H22N6O | 2230850-47-0 | Details |
| Endoxifen (E-isomer)；Endoxifen E-isomer;E-Endoxifen | C25H27NO2 | 114828-90-9 | Details |
| Enniatin A1 | C35H61N3O9 | 4530-21-6 | Details |
| Enniatin complex | C36H63N3O9.C35H61N3O9.C34H59N3O9.C33H57N3O9 | 11113-62-5 | Details |
| Dacarbazine；DTIC-Dome;Imidazole Carboxamide | C6H10N6O | 4342-03-4 | Details |
| Endothelial lipase inhibitor-1 | C22H22N4O4 | 1466427-02-0 | Details |
| Endomorphin 2 TFA | C34H38F3N5O7 | 1276124-00-5 | Details |
| Emixustat hydrochloride；ACU-4429 hydrochloride | C16H26ClNO2 | 1141934-97-5 | Details |
| Emtricitabine S-oxide；Emtricitabine sulfoxide;Emtricitabine Degradant-III | C8H10FN3O4S | 152128-77-3 | Details |
| Rasagiline；TVP1012;AGN1135 | C12H13N | 136236-51-6 | Details |
| EMT inhibitor-1 | C12H12Cl2N2O2S | 1638526-21-2 | Details |
| EN6 | C19H14F2N4O2 | 1808714-73-9 | Details |
| Enalapril D5 maleate；MK-421 D5 maleate | C24H27D5N2O9 | 349554-02-5 | Details |
| Enalaprilat-d5 sodium；Enalaprilat D5 Sodium Salt;MK-422 D5 Sodium Salt | C18H18D5N2NaO5 | 1356922-29-6 | Details |
| Enalaprilat D5；MK-422 D5 | C18H19D5N2O5 | 349554-00-3 | Details |
| Enazadrem | C18H25N3O | 107361-33-1 | Details |
| Product Total： Product Page： | ||||
| 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 | ||||